ASELAGE STEVE 4
4 · Travere Therapeutics, Inc. · Filed Nov 9, 2021
Insider Transaction Report
Form 4
ASELAGE STEVE
Director
Transactions
- Sale
Common Stock
2021-11-05$26.23/sh−10,000$262,300→ 161,794 total - Exercise/Conversion
Common Stock
2021-11-05$16.23/sh+10,000$162,300→ 171,794 total - Exercise/Conversion
Employee stock option (right to buy)
2021-11-05−10,000→ 70,000 totalExercise: $16.23Exp: 2026-05-18→ Common Stock (10,000 underlying)
Holdings
- 19,500(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to an automatic trading plan adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]The shares are held in the name of the Aselage Family Trust.
- [F3]The stock option is fully vested and exercisable.